Volume 15, Number 11—November 2009
Letter
Imported Human Fascioliasis, United Kingdom
Table
Characteristics of human fascioliasis case-patients during enhanced surveillance, United Kingdom, January 1, 2008–January 31, 2009*
Case no. | Age, y/sex | Country of origin | Years since migration | Other travel | Risk factor | Clinical features | Eosinophil count, x109/L) | Abnormal liver function | Hepatic imaging | IFAT† |
1 | 45/F | Yemen | 7 | Yemen regularly | Khat use | Abdominal pain | 8.4 | Yes | Mixed-density liver lesion (CT) | 1:128 |
2 | 44/M | Somalia | 16 | Ethiopia 2007 | Khat use | Fever, abdominal pain | 3.4 | Yes | Serpiginous lesion (MRI) | 1:64 |
3 | 34/F | Ethiopia | 3 | S. Africa regularly | Khat use | Fever, abdominal pain | 11.4 | No | Heterogeneous lesion (USS) | 1:128 |
4 | 44/F | Somalia | 7 | Somalia 2004, Netherlands | Khat use | Abdominal pain | 8.3 | No | Heterogeneous lesion (USS) | 1:128 |
5 | 54/F | Somalia | 21 (to Netherlands), 4 (to UK) | None | Khat use | Anorexia | 8.4 | No | Low-density lesion (CT) | 1:32 |
6 | 43/M | Somalia | 28 (to India), 21 (to UK) | None | Khat use | Fever | 1.0 | Yes | Heterogeneous lesion (USS) | 1:128 |
7 | 28/F | UK | – | Uganda 2007–2008 | – | Abdominal pain, hepatomegaly | 1.84 | Yes | Hepatomegaly with large mixed cystic and solid lesion (USS) | 1:512 |
8 | 67/M | UK | – | Kenya 2008, prior world travel | – | Malaise, abdominal pain | 0.04 | Yes | Multiple gallstones (MRCP) | 1:256 |
9 | 38/M | Ethiopia | 10 | Ethiopia 2006 | – | Abdominal pain, fever | 18.7 | Yes | Normal (USS, MRCP) | 1:128 |
10 | 28/M | Ethiopia | Unknown | Unknown | – | Fever, gram- negative sepsis; new HIV diagnosis | <0.04 | Yes | Lesion in hepatic vein | 1:64 |
11 | 47/F | Somalia | 16 (to Yemen), 6 (to UK) | Unknown | Khat use | Abdominal pain, fever | 16.8 | Yes | Low-density lesion (CT) | 1:256 |
*IFAT, immunofluorescent antibody test; CT, computed tomography; MRI, magnetic resonance imaging; USS, ultrasound scan, MRCP, magnetic resonance cholangiopancreatography.
†Titer of IFAT (screening titer 32).